2018年
Development of targeted metabolomics for the determination of ornithine cycle compounds as possible biomarkers in cerebrospinal fluid regarding to Alzheimer's disease pathology using UHPLC-ESI-MS/MS.
Med. Mass Spectrometry
- ,
- ,
- ,
- ,
- ,
- 巻
- 2
- 号
- 開始ページ
- 11-20
- 終了ページ
- DOI
- 10.24508/mms.2018.06.001
- ID情報
-
- DOI : 10.24508/mms.2018.06.001